Daclizumab high-yield process in relapsing-remitting multiple sclerosis (SELECT): a randomised, double-blind, placebo-controlled trial.

Research output: Contribution to journal › Article › peer-review

Access to Document

@article{500a74d9188146f29f9c947ca33af9e4,

title = "Daclizumab high-yield process in relapsing-remitting multiple sclerosis (SELECT): a randomised, double-blind, placebo-controlled trial.",

author = "Zajicek, {John Peter}",

year = "2013",

doi = "10.1016/S0140-6736(12)62190-4",

language = "English",

journal = "Lancet",

issn = "0037-9808",

publisher = "Elsevier Inc.",

}